ChemicalBook > CAS DataBase List > Idarubicin

Idarubicin

Idarubicin Structure
Idarubicin
  • CAS No.58957-92-9
  • Chemical Name:Idarubicin
  • CBNumber:CB5283235
  • Molecular Formula:C26H27NO9
  • Formula Weight:497.49
  • MOL File:58957-92-9.mol
Idarubicin Property
  • Boiling point 589.46°C (rough estimate)
  • Density 1.3477 (rough estimate)
  • refractive index 1.6000 (estimate)
  • storage temp. Keep in dark place,Sealed in dry,2-8°C
  • form solid
  • pka pKa 4.73± 0.21 (Uncertain)
  • NCI Dictionary of Cancer Terms 4-demethoxydaunorubicin
  • FDA UNII ZRP63D75JW
  • ATC code L01DB06
Safety
  • Hazard Codes  :T+
  • Risk Statements  :60-61-28-40
  • Safety Statements  :53-45
  • RIDADR  :UN 2811 6.1/PG 2
  • WGK Germany  :3
  • RTECS  :HB7877000
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal word
  • Hazard statements
  • Precautionary statements

Idarubicin Chemical Properties,Usage,Production

  • Uses Antineoplastic.
  • Definition ChEBI: Idarubicin is a monosaccharide derivative, an anthracycline antibiotic and a deoxy hexoside. It derives from a hydride of a tetracene.
  • Indications Idarubicin (Idamycin) differs from its parent compound, daunorubicin, by the absence of the methoxy group in the anthracycline ring structure. Its mechanisms of action and resistance are similar to those of doxorubicin and daunorubicin; however, it is more lipophilic and more potent than these other anthracyclines. Idarubicin undergoes extensive hepatic metabolism and biliary excretion. Adverse reactions of idarubicin are similar to those of its congeners.
  • IC 50 Topoisomerase II
Idarubicin Preparation Products And Raw materials
Raw materials
Preparation Products
Global(131)Suppliers
  • Supplier:
    career henan chemical co
  • Tel:+86-0371-86658258<br/>+8613203830695
  • Email:factory@coreychem.com
  • Country:China
  • ProdList:29808
  • Advantage:58
  • Supplier:
    Shanghai UCHEM Inc.
  • Tel:+862156762820<br/>+86-13564624040
  • Email:sales@myuchem.com
  • Country:China
  • ProdList:7906
  • Advantage:58
Idarubicin Spectrum
58957-92-9, IdarubicinRelated Search:
  • Active Pharmaceutical Ingredients
  • 抑制剂
  • 医药原料药
  • 科研原药系列
  • 抗肿瘤药
  • 原料药【仅供科研】
  • 药物
  • 其它抗生素
  • 抗生素
  • BICINS比星类产品(Anti-cancer)
  • DNA metabolism
  • DNA Synthesis Inhibitors
  • BioChemical
  • Cell Biology
  • Cell Signaling and Neuroscience
  • Apoptosis and Cell Cycle
  • C26H27NO9
  • 化合物 IDARUBICIN
  • 英文名称:IDARUBICIN
  • 化合物 T4791
  • 依达比星盐酸盐 100MG
  • 依达比星盐酸盐
  • 伊达比星
  • (1S,3S)-3-乙酰-1,2,3,4,6,11-六氢-3,15,12-三羟基-6,11-二氧代-L-丁炔基-3-氨基-2,3,6-三脱氧基-Α-L-来苏糖吡喃己糖苷
  • 伊达吡星
  • 4-去甲氧基柔红霉素
  • 依达比星
  • 58957-92-9
  • IdarubicinQ: What is Idarubicin Q: What is the CAS Number of Idarubicin Q: What is the storage condition of Idarubicin Q: What are the applications of Idarubicin
  • Idarubicin USP/EP/BP
  • Idarubicin ( 4-Demethoxydaunorubicin
  • CS-704
  • IMI-30:NSC-256439
  • (7S-cis)-9-Acetyl-7-[(3-amincr2,3,6-trideoxy-α-L-lyxohexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
  • (7S,9S)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
  • Idarubicin HCL(BICINS)
  • Demethoxydaunorubicin
  • 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-
  • 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S,9S)-
  • 4-DMD
  • 1-Demethoxydaunorubicin
  • 5,12-Naphthacenedione, 9-acetyl-7-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S,9S)-
  • IDARUBICIN HCL
  • IDARUBICIN
  • IDAMYCIN
  • IMI-30
  • DMDR
  • (7S-CIS)-9-ACETYL-7-[(3-AMINO-2,3,6-TRIDEOXY-ALPHA-L-LYXO-HEXOPYRANOSYL)OXY]-7,8,9,10-TETRAHYDRO-6,9,11-TRIHYDROXY-5,12-NAPHTHACENEDIONE
  • (7S,9S)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
  • (7S)-9-Acetyl-7β-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9β,11-trihydroxy-5,12-naphthacenedione
  • nsc-256439
  • 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-12-naphthacenedione
  • 4-Demethoxy-daunorubicin
  • 4-demethoxydaunorubicin
  • 4-demethoxydaunomycin
  • 4-demethoxy-daunomyci
  • 11-trihydroxy-(7s-cis)-alpha-l-lyxo-hexopyranosyl)oxy)-